Drug Shortage Report for ACT TERBINAFINE
Report ID | 111874 |
Drug Identification Number | 02254727 |
Brand name | ACT TERBINAFINE |
Common or Proper name | TERBINAFINE 250MG TABLET |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TERBINAFINE |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | D01BA |
ATC description | ANTIFUNGALS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-08 |
Estimated end date | |
Actual end date | 2020-05-31 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | Item is under review to be discontinued - Transitioned |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-02-25 | English | Compare |
v10 | 2020-12-10 | French | Compare |
v9 | 2020-12-10 | English | Compare |
v8 | 2020-08-20 | French | Compare |
v7 | 2020-08-20 | English | Compare |
v6 | 2020-06-11 | French | Compare |
v5 | 2020-06-11 | English | Compare |
v4 | 2020-05-14 | French | Compare |
v3 | 2020-05-14 | English | Compare |
v2 | 2020-04-10 | French | Compare |
v1 | 2020-04-10 | English | Compare |